Related Experiment Video
Updated: Jun 29, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
Acute otitis media: making sense of recent guidelines on antimicrobial treatment
Michael E Pichichero1, Janet R Casey
1University of Rochester Medical Center, Elmwood Pediatric Group, 601 Elmwood Avenue, Box 672, Rochester, NY 14642, USA. michael_pichichero@urmc.rochester.edu
Abstract:
High-dose amoxicillin (80 to 90 mg/kg/d divided twice daily) remains the drug of choice for treatment of acute otitis media despite increasing antimicrobial resistance. For persistent or recurrent acute otitis media, guidelines recommend high-dose amoxicillin/clavulanate (90/6.4 mg/kg/d), cefdinir, cefprozil, cefpodoxime, cefuroxime, or ceftriaxone. Increasing the dose of amoxicillin does not cover infection with beta-lactamase-producing pathogens; add the beta-lactamase inhibitor clavulanate to amoxicillin, or choose a cephalosporin with good activity against S pneumoniae and good beta-lactamase stability. Key factors for enhancing compliance are taste of suspension, dosing frequency, and duration of therapy.
Insights
High-dose amoxicillin is recommended for acute otitis media, but resistance is rising. For persistent cases, amoxicillin/clavulanate or alternative antibiotics are advised to combat beta-lactamase-producing bacteria.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Acute otitis media (AOM) treatment guidelines recommend high-dose amoxicillin.
- Increasing antimicrobial resistance poses a challenge to amoxicillin efficacy.
- Beta-lactamase-producing pathogens complicate AOM treatment.
Purpose of the Study:
- To review current recommendations for AOM treatment.
- To address the challenge of antimicrobial resistance in AOM.
- To identify effective antibiotic strategies for persistent or recurrent AOM.
Main Methods:
- Review of clinical guidelines and antimicrobial resistance data.
- Analysis of antibiotic classes effective against common AOM pathogens.
- Consideration of factors influencing patient compliance.
Main Results:
- High-dose amoxicillin is the first-line treatment for AOM.
- Amoxicillin/clavulanate or alternative antibiotics (cefdinir, cefprozil, cefpodoxime, cefuroxime, ceftriaxone) are recommended for persistent/recurrent AOM.
- Increasing amoxicillin dose alone does not overcome beta-lactamase resistance; clavulanate or beta-lactamase stable cephalosporins are necessary.
Conclusions:
- Amoxicillin remains a primary choice for AOM, but resistance necessitates alternative strategies.
- Amoxicillin/clavulanate or specific cephalosporins are crucial for treating resistant AOM.
- Optimizing antibiotic selection and considering compliance factors are key for effective AOM management.
Related Concept Videos
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Tonsillitis II: Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

